Turtle Turtle CJ CJ Hay Hay KA KA Hanafi Hanafi L-A L-A Durable molecular remissions in chronic lymphocytic leukemia treated with CD19-specific chimeric antigen receptor-modified T cells after failure of ibrutinib Durable molecular remissions in chronic lymphocytic leukemia treated with CD19-specific chimeric antigen receptor-modified T cells after failure of ibrutinib J Clin Oncol J Clin Oncol 2017 2017 35 35 26 26 3010 3010 3020 3020 10.1200/JCO.2017.72.8519 10.1200/JCO.2017.72.8519 28715249 28715249. This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.